Non-Oncologic Total Femoral Arthroplasty: Retrospective Review

Derek F. Amanatullah, Robert T. Trousdale, Arlen D. Hanssen, David G. Lewallen, Michael J. Taunton

Research output: Contribution to journalArticlepeer-review

18 Scopus citations


Total femoral arthroplasty (TFA) is an option to amputation in the setting of excessive bones loss during revision total hip and knee arthroplasty. Twenty non-oncologic TFAs with a minimum of 2. years follow-up were retrospectively reviewed. The average clinical follow-up was 73. ±. 49. months. The incidence of new infection was 25% (5/20), while the overall infection rate was 35% (7/20). The incidence of primary hip instability was 10% (2/20), while the overall instability rate was 25% (5/20). Six patients (30%) required revision. The average pre-operative HHS was 30.2. ±. 13.1. The average post-operative HHS was 65.3. ±. 16.9. TFA is a viable alternative to amputation in non-oncologic patients with massive femoral bone deficiency. However, TFA performed poorly in the setting of infection and instability.

Original languageEnglish (US)
Pages (from-to)2013-2015
Number of pages3
JournalJournal of Arthroplasty
Issue number10
StatePublished - Oct 1 2014


  • Above knee amputation
  • Compromised bone stock
  • Hip disarticulation
  • TFA
  • Total femoral arthroplasty

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine


Dive into the research topics of 'Non-Oncologic Total Femoral Arthroplasty: Retrospective Review'. Together they form a unique fingerprint.

Cite this